Joon Lee
Stock Analyst at Truist Securities
(4.64)
# 145
Out of 4,944 analysts
111
Total ratings
53.21%
Success rate
40.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $395.92 | +23.76% | 4 | Aug 5, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $80 → $86 | $48.17 | +78.53% | 2 | Jul 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $41.27 | +81.73% | 8 | Apr 28, 2025 | |
| ARVN Arvinas | Maintains: Buy | $65 → $21 | $7.09 | +196.19% | 6 | Apr 9, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $76 → $150 | $72.80 | +106.04% | 8 | Mar 31, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $90 → $50 | $11.00 | +354.55% | 4 | Mar 4, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $175 → $85 | $49.05 | +73.29% | 5 | Mar 3, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $190 → $200 | $109.39 | +82.83% | 5 | Feb 19, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $100 → $120 | $57.33 | +109.31% | 5 | Feb 12, 2025 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $18 | $3.72 | +383.87% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $660 → $700 | $646.60 | +8.26% | 12 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 → $57 | $105.20 | -45.82% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.68 | +139.52% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $8.76 | +310.96% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $20.19 | +78.31% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.08 | +159.74% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $12.08 | +40.73% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $118 → $90 | $58.30 | +54.37% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $2.66 | +1,403.76% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $117.12 | +70.77% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $3.03 | +65.02% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.65 | +393.15% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.47 | +11,236.03% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $20.74 | +63.97% | 1 | Mar 16, 2021 |
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $395.92
Upside: +23.76%
PTC Therapeutics
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $48.17
Upside: +78.53%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $41.27
Upside: +81.73%
Arvinas
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $7.09
Upside: +196.19%
Corcept Therapeutics
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $72.80
Upside: +106.04%
Intellia Therapeutics
Mar 4, 2025
Maintains: Buy
Price Target: $90 → $50
Current: $11.00
Upside: +354.55%
Praxis Precision Medicines
Mar 3, 2025
Maintains: Buy
Price Target: $175 → $85
Current: $49.05
Upside: +73.29%
Axsome Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $109.39
Upside: +82.83%
CRISPR Therapeutics AG
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $57.33
Upside: +109.31%
Larimar Therapeutics
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.72
Upside: +383.87%
Jan 14, 2025
Reiterates: Buy
Price Target: $660 → $700
Current: $646.60
Upside: +8.26%
Jan 8, 2025
Reiterates: Buy
Price Target: $44 → $57
Current: $105.20
Upside: -45.82%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $6.68
Upside: +139.52%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $8.76
Upside: +310.96%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $20.19
Upside: +78.31%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $3.08
Upside: +159.74%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $12.08
Upside: +40.73%
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $58.30
Upside: +54.37%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $2.66
Upside: +1,403.76%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $117.12
Upside: +70.77%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $3.03
Upside: +65.02%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.65
Upside: +393.15%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.47
Upside: +11,236.03%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $20.74
Upside: +63.97%